NASDAQ:SGYP
Delisted

Synergy Pharmaceuticals Stock Predictions

etoro logo Buy SGYP
*Your capital is at risk
$0.0064
+0 (+0%)
At Close: Sep 17, 2019
Currently predicting for Mon, 8 Jun 2026

SGYP Prediction Chart

SGYP Predictions History

Latest community submissions for SGYP.
Predictor Target Session Target Price Result Direction Accuracy Score
May 6, 2019 $0.0100 +56.25% $0.0064 X 43.75% 0
Gp Gp Merchant @Gp.98898
Mar 11, 2019 $0.0400 +59.36% $0.0251 X 40.60% 0
JS JS Pro
Mar 11, 2019 $0.0300 +19.52% $0.0251 X 80.50% 0
JS JS Pro
Mar 5, 2019 $0.0650 +9.24% $0.0595 X 90.80% 0
JS JS Pro
Mar 1, 2019 $0.0920 +26.72% $0.0726 X 73.30% 0
Mar 1, 2019 $0.0910 +25.34% $0.0726 X 74.70% 0
Gp Gp Merchant @Gp.98898
Mar 1, 2019 $0.130 +79.06% $0.0726 X 20.90% 0
Mar 1, 2019 $0.250 +244.35% Unrealistic Excluded from avg $0.0726 X 0.00% 0
Feb 25, 2019 $0.299 +24.53% $0.240 X 75.50% 0
JS JS Pro
Feb 25, 2019 $0.288 +19.95% $0.240 X 80.00% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SGYP with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SYNERGY PHARMACEUTICALS
Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company is also developing SP-333,...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE